Related Experiment Video
Updated: Aug 5, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
[Late onset Wilson's disease]
1Dipartimento di Citomorfologia, Università di Cagliari, Ospedale San Giovanni di Dio, Cagliari.
Pathologica
|November 5, 2004
Summary
Late-onset Wilson's disease (W.D.) is not rare in the Sardinian population, often presenting with mild to severe liver disease. Consider W.D. in adults with unexplained chronic liver disease, even over 35.
Area of Science:
- Hepatology
- Metabolic Disorders
- Genetics
Context:
- Wilson's disease (W.D.) is a rare metabolic disorder typically diagnosed in younger individuals.
- Adult-onset W.D. presentation is less common, necessitating further investigation into its prevalence and characteristics.
- This study focuses on Sardinian adults aged 36-57 diagnosed with W.D.
Purpose:
- To determine the prevalence and clinical presentation of Wilson's disease in adults.
- To analyze the age of onset and liver disease stage at presentation in adult W.D. patients.
- To investigate W.D. genetic mutations in the Sardinian population.
Summary:
- Eleven adult Sardinian patients with W.D. (age >35) were analyzed for liver histology and copper staining.
- Liver biopsies revealed varying stages of liver disease, from steatosis to cirrhosis.
- Molecular analysis identified the common Sardinian W.D. gene mutation (-441/-427 del, 5' UTR) in most cases.
Impact:
- Highlights that Wilson's disease can manifest in adulthood, even with advanced liver disease.
- Suggests considering W.D. in the differential diagnosis of chronic liver disease of unknown etiology in adults.
- Provides insights into the genetic landscape of W.D. in the Sardinian population.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
06:52Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Related Concept Videos
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...